New Jersey is the medicine chest to the world. Our diverse ecosystem of life science companies range from biotechnology to medical device to regenerative medicine. NJ is the birthplace of immunotherapy and the cure for hepatitis C.
We are the home of the first ever approved CAR-T cell therapy and 3D printed drug. We are the home to 63 universities, colleges and technical schools, 4 medical schools, 13 teaching hospitals, over 1500 active/open clinical trials, along with 3,000 life science and biopharma establishments.
Whether you are a stateside scientist or an international life science company, NJ is a place where your innovation can get started, get established and grow.
SIX FOCUS AREAS OF LIFE SCIENCES
life science and biopharma establishments
active/open clinical trials
ResearchwithNJ.com is more than just a place to get information: it is a dynamic community of collaborative networks and news about the New Jersey’s unique culture of innovation. It is an online gateway that lets New Jersey’s entrepreneurs and commercial enterprises identify experts, facilities, publications, intellectual property, news, and events in five of the state’s universities: Princeton University, Rutgers University, New Jersey Institute of Technology, and Rowan University.
Located in the heart of New Jersey’s “Research Corridor” the 50-acre research park is designed to meet the research, manufacturing and office needs of entrepreneurial startups, to emerging research companies, large established corporations in the bioscience and pharmaceutical industries.
The New Jersey Bioscience Center is home to the Incubator and Step-Out Labs of North Brunswick and consists of almost 300,000 S.F. of lab and office space with over $70 million invested in facilities and improvements including a shared conference facility.
TRENTON, N.J. (August 10, 2021) – The New Jersey Commission on Science, Innovation and Technology today announced that it will open applications for a $1.25 million round of grant funding through its New Jersey Small Business Innovation Research (SBIR) and…
Read More >TRENTON, N.J. (June 25, 2021) – The New Jersey Economic Development Authority (NJEDA) today reminded New Jersey’s emerging technology and life sciences companies that they have until June 30 to apply to the state’s Net Operating Loss (NOL) Program.
Read More >TRENTON, N.J. (May 19, 2021) – The NJEDA today announced that it is accepting public feedback on the proposed rules for the expanded Angel Investor Tax Credit Program. Members of the public can read the draft rules and provide written feedback at www.njeda.com/program-specific-feedback.
Read More >
